IGC Pharma, Inc. IGC
Set alert
0.19 USD 0.00 +1.04%
As of Nov 3, 10:43 AM ET
0.1927 Day range 0.1973
0.08 52-week range 0.40
- YTD
- -30.39%
- 1 year
- -51.28%
- Open
- 0.1927
- Prev close
- 0.1929
- Mkt cap
- 20.15M
- Vol
- 55.10K
- Avg vol
- 752.75K
- EPS
- -0.07
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1927
- High
- 0.1973
- Forward P/E
- -3.74
- Beta
- 1.29
- Short ratio
- 2.29
- Inst. own
- 22.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 0.3768
- 200-d avg
- 0.421
- 1y target
- 3.75
Analyst view
Consensus: none
Price target (mean) 3.75 +1824.1% upside
Now 0.1949
- Target (low)
- 3.50
- Target (mean)
- 3.75
- Target (high)
- 4.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.03 | -0.03 – -0.03 | -0.0465 | +35.5% | 204.00K | 0.0% | 2 |
| Next quarter | -0.03 | -0.03 – -0.03 | -0.0328 | +8.5% | 295.00K | 0.0% | 2 |
| Current year | -0.11 | -0.11 – -0.11 | -0.1641 | +33.0% | 1.18M | -12.0% | 1 |
| Next year | -0.12 | -0.12 – -0.12 | -0.11 | -9.1% | 1.35M | +14.2% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Sep 3, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Jul 29, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Jul 17, 2024 | Alliance Global Partners | Initiated | — | Buy |
| Jun 21, 2024 | Ascendiant Capital | Reiterated | Buy | Buy |